Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
| Total reported revenue | 1.7B | 1.9B | 1.7B | 1.7B |
| Cost of revenue | 1.3B | 1.3B | 1.2B | 1.5B |
| Gross profit | 382M | 606M | 463M | 161M |
| Operating expense | ||||
| Research & development | 285M | 279M | 277M | 246M |
| Selling general and admin | 139M | 142M | 107M | 113M |
| Other operating expenses | — | 21M | — | 34M |
| Operating income | -42M | 185M | 79M | -198M |
| Non operating interest income | ||||
| Income | 6M | 2M | 3M | 3M |
| Expense | 16M | 4M | 9M | 11M |
| Other income expense | -1.8B | -10M | -19M | -54M |
| Pretax income | -1.9B | 173M | 54M | -260M |
| Tax provision | 32M | 69M | 27M | 41M |
| Net income | -1.9B | 104M | 27M | -301M |
| Basic EPS | -13.3 | 0.7 | 0.2 | -2.1 |
| Diluted EPS | -13.3 | 0.7 | 0.2 | -2.1 |
| Basic average shares | 145M | 144M | 145M | 145M |
| Diluted average shares | 145M | 144M | 145M | 145M |
| EBITDA | -9M | 167M | 133M | -202M |
| Net income from continuing op. | -1.9B | — | 27M | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |